Hoth Therapeutics Inc. (HOTH)
NASDAQ: HOTH
· Real-Time Price · USD
1.34
0.01 (0.75%)
At close: Sep 04, 2025, 3:59 PM
1.31
-2.24%
Pre-market: Sep 05, 2025, 09:21 AM EDT
0.75% (1D)
| Bid | 1.31 |
| Market Cap | 17.77M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.19M |
| EPS (ttm) | -1.04 |
| PE Ratio (ttm) | -1.29 |
| Forward PE | -2.25 |
| Analyst | Buy |
| Ask | 1.36 |
| Volume | 1,671,928 |
| Avg. Volume (20D) | 1,034,190 |
| Open | 1.33 |
| Previous Close | 1.33 |
| Day's Range | 1.25 - 1.38 |
| 52-Week Range | 0.65 - 3.80 |
| Beta | 0.67 |
About HOTH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HOTH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HOTH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
+10.34%
Hoth Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
8 months ago
+178.18%
Hoth Therapeutics shares are trading higher after the company announced safety results from its Phase 2a trial, showing that 100% of patients in Cohort 1 achieved the primary efficacy endpoint.
